🧫 KinExA — Kinetic Exclusion Assay

Figure 1 schematic explaining kinetic exclusion assay: solution pre-equilibrium of antibody and antigen, rapid bead-column capture of free antibody, fluorescent detection of captured antibody, and decreasing equilibrium KD curve

KinExA (Kinetic Exclusion Assay) measures the equilibrium dissociation constant KD of binding partners that stay unmodified in solution during the equilibrium itself. Antigen and antibody are mixed at known concentrations, allowed to reach equilibrium, and then briefly drawn through a column of antigen-coated beads. The contact time is too short for re-equilibration, so only the free antibody population is captured on the column and quantified by a labeled secondary. By titrating across many equilibrium mixtures, the free-antibody fraction is fit to the 1:1 binding quadratic to extract KD. The equilibrium pair never sees a label or a surface — though the assay itself still uses an antigen-coated bead column for capture and a labeled secondary for detection, both contacted only after equilibrium is reached.

🧪

Solution-phase equilibrium

The Ab–Ag equilibrium itself happens in free solution — no immobilization or tethering of either equilibrium partner. The bead column captures the free fraction post-equilibration; it does not perturb the equilibrium.

🔬

Unmodified equilibrium partners

The pair you characterize stays unlabeled and untethered through the binding event itself. (The assay still requires a coated bead column and a labeled detection reagent — they touch only after equilibrium is reached.)

🎯

Femtomolar KD

Sensitivity is set by how dilute you can run the receptor and still detect free signal — often pM, with fM achievable for high-quality systems.

⚖️

Active concentration

Can determine the active fraction of binding sites independently of total protein — invaluable for batch QC.

⏱️

Slow kinetics too

kon can be extracted from a kinetics curve (mixture sampled at multiple pre-equilibration times). Best for slow on-rates.

🛡️

No equilibrium-step surface bias

The Ab–Ag equilibrium runs in solution, free of surface-mediated avidity and mass-transport bias. (Bead-capture artifacts — non-specific bead binding, free-Ab rebinding during transit at fast off-rates — still apply to the readout.)

Key Physics Concepts

⏱️ Kinetic Exclusion

  • Pre-equilibrated mixture of antibody (Ab) and antigen (Ag) is drawn through an Ag-coated bead column
  • Bead contact time (∼0.5–1.5 s) is much shorter than the complex's dissociation half-life
  • Result: complexes survive intact through the column; only free Ab is captured
  • Captured Ab is detected by a fluorescent secondary → signal ∝ free [Ab] in the equilibrium mixture

📉 KD- vs Receptor-Controlled Curves

  • KD-controlled curve: [Ab] ≪ KD. Curve's midpoint is KD itself — direct readout of affinity
  • Receptor-controlled curve: [Ab] ≫ KD. Curve's midpoint is set by [Ab] (stoichiometric titration) — gives active concentration of antigen
  • Best practice: run several titrations at different [Ab] and fit them simultaneously — Sapidyne calls this an n-curve analysis. The combined fit constrains KD, [Ab]active, and [Ag]active at once

🐢 Slow Kinetics by Time Sampling

  • Mix Ab + Ag and assay free Ab at multiple times before equilibrium is reached
  • Free-Ab decay vs. time → fit a pseudo-first-order approach to equilibrium → extract kon (with KD from the equilibrium curve, koff = KD · kon)
  • Particularly useful for slow on-rates (kon ≲ 10⁵ M⁻¹ s⁻¹) where SPR/BLI association windows are unhelpfully long

🧫 KinExA vs 📡 Surface Biosensors (SPR / BLI / GCI)

Solution equilibrium versus surface kinetics — different physics, different sweet spots.

KinExASPR / BLI / GCI
FormatSolution equilibrium + bead-column captureSurface kinetics in real time
ModificationEquilibrium pair unmodified (capture beads + labeled detection still required)One partner immobilized (often via tag/biotin)
Practical KD floorReaches fM with optimised, low-receptor titrations; pM is routineHighly instrument- and analyte-dependent (≈pM at best with high-MW analytes, nM for fragments)
kon, koffkon for slow systems; koff via KD · konDirect, real-time
Surface artifactsNo surface-mediated avidity or mass transport during the equilibrium step; bead-capture artifacts (NSB, residence-time bias for fast off-rates) still applyAvidity, mass transport, rebinding for tight binders
Active concentrationYes (k-curve)Indirect (CFCA on some platforms)
ThroughputLow (hours per KD)High (many samples in parallel)
Best forTight KD, unmodified pairsKinetics, screening, mid-range affinities

How KinExA Works — Practical Guide

🔬 Experimental Setup

  1. Instrument: Sapidyne KinExA 4000 (current) or KinExA 3200 (earlier generation) — flow-based bead column with fluorescence detection
  2. Beads: Coat porous beads (e.g., azlactone or NHS-activated) with antigen at high density. Pack a small column for each measurement
  3. Equilibrium mixtures: series of vials at fixed [Ab] (well below expected KD for a KD-controlled curve), titrated [Ag]. Equilibrate (hours to days for tight systems)
  4. Sample volume: Larger volumes are pulled through the column to accumulate signal at low [Ab] — typically 0.5–10 mL per sample, scaling up to ~60 mL when chasing sub-pM KD (Bee et al. 2012)
  5. Detection: Labeled secondary antibody (anti-Ig, fluorophore) flows after the sample → signal ∝ free Ab captured
  6. Run: Each sample takes minutes; a full titration ranges from a few hours to overnight

📊 Data Analysis

  1. Free fraction: Normalize signal to the no-antigen control ([Ab]free / [Ab]T)
  2. Plot: Free fraction vs. log [Ag]T
  3. Fit: 1:1 quadratic binding equation → KD and active fractions
  4. Combine regimes: simultaneously fit a KD-controlled curve ([Ab] ≪ KD) and a receptor-controlled curve ([Ab] ≫ KD) — Sapidyne's "n-curve" analysis — for orthogonal constraints on KDand active concentrations
  5. Confidence interval: Sapidyne software returns 95% CI from bootstrap or profile-likelihood; report this, not just the point estimate
  6. Quality check: Inspect residuals; ensure curve spans the inflection in both directions

Key Quantities

QuantitySymbolTypical rangeWhat it tells you
Dissociation constantKD~100 fM – 100 nM (sub-100 fM with heroic optimisation)Equilibrium affinity
[Ab] for KD-controlled curve[Ab]T≲ KD (often pM–fM for tight systems)Sets sensitivity; lower [Ab] resolves smaller KD
[Ab] for receptor-controlled curve[Ab]T≫ KDProbes active [Ag] (stoichiometric titration)
Active fractionfactive0–1Fraction of protein that is binding-competent
Association ratekon10³ – 10⁶ M⁻¹ s⁻¹ (the niche where SPR struggles)From the time-course; KinExA's sweet spot is kon low enough that SPR association windows would be impractical
Dissociation ratekoff≲ 10⁻³ s⁻¹koff = KD · kon (derived)
Equilibration timeteqHours – days for tight systems~5/kobs; very tight pairs need long incubation
Sample volumeV~0.5–10 mL/run (up to ~60 mL for sub-pM binders)Larger V at low [Ab] to build signal

Common Pitfalls

Insufficient equilibration

For fM–pM KD, equilibration takes hours to days. Stopping early biases the apparent KD upward. Verify with a time-course at the lowest [Ag] used.

Fast dissociators

koff ≳ 10⁻² s⁻¹ starts to violate the kinetic-exclusion assumption — complexes dissociate during column transit and free-Ab fraction is biased high. KinExA is best for koff ≲ 10⁻³ s⁻¹; use SPR/BLI instead for faster off-rates.

[Ab] not low enough to resolve KD

If [Ab]T ≳ KD, the curve drifts into the receptor-controlled regime and KD is only bounded, not resolved. Drop [Ab] until the curve midpoint stops shifting with [Ab].

Bead saturation / non-specific binding

Over-coated beads or matrix binding cause baseline drift. Run buffer-only controls and validate with a non-binding isotype.

Active concentration error

Total [Ab] from absorbance ≠ active [Ab]. Run a receptor-controlled curve to determine active concentration and use it as a constraint when fitting the KD-controlled curve.

Bivalent antibody, monovalent KD?

IgGs are bivalent; reported KD is the monovalent intrinsic affinity only when antigen is monovalent and avidity is excluded. Check via Fab vs IgG comparison.

Adsorption to plasticware

fM–pM proteins lose to surfaces. Use low-bind tubes, carrier protein (BSA), and silanized glass where possible.

Reporting only the point estimate

Without a confidence interval, a fM KD claim is not interpretable. Always report 95% CI from bootstrap or profile-likelihood.

Strengths & Limitations

✅ Strengths

  • • Femtomolar-to-picomolar KD, well below typical SPR/BLI floors
  • • Equilibrium partners stay unmodified (capture beads + labeled detection only contact the sample after the equilibrium step)
  • • No surface-mediated avidity or mass-transport bias during the equilibrium itself
  • • Active concentration determination via the receptor-controlled (k-curve) regime
  • • Combined fit of KD-controlled + receptor-controlled curves ("n-curve" simultaneous fit) constrains KD, active [Ab], and active [Ag] together
  • • kon accessible for slow systems via time-course sampling

⚠️ Limitations

  • • Low throughput — hours to overnight per KD
  • • koff must be slow (t½ ≫ column transit time, typically koff ≲ 10⁻³ s⁻¹)
  • • Not a real-time kinetics method — koff is derived, not observed
  • • Single instrument vendor (Sapidyne)
  • • Need a labeled secondary that recognizes the receptor (or direct label on Ab)
  • • Sample consumption (mL volumes) higher than chip-based methods at high [Ab]
  • • Bead-column preparation is part of the workflow — not plug-and-play

When to Use KinExA — and When Not

✅ Sub-pM affinities

Therapeutic antibodies, affinity-matured binders, anti-toxins. SPR/BLI floors leave you reporting only KD < limit.

✅ Tag-free equilibrium partners

When biotinylation or surface coupling of the binding pair perturbs binding (regulatory submissions, native-state characterization). The equilibrium partners stay untouched; the bead and detection reagents only contact the sample after the equilibrium step.

✅ Active-concentration QC

Lot release for biologics — KinExA k-curves give absolute active concentration.

⚠️ Fast off-rates

koff ≳ 10⁻² s⁻¹ starts to violate the kinetic-exclusion assumption (KinExA is best for koff ≲ 10⁻³ s⁻¹). Use SPR/BLI/GCI for faster off-rates.

⚠️ Need real-time kinetics

koff is derived (KD · kon), not observed. SPR is the right tool for kon, koff measurement.

⚠️ High-throughput screening

Hours per KD rules out primary screening campaigns. Use SPR/BLI/HTRF/ AlphaLISA upstream and confirm tight hits with KinExA.

Technique Comparison

🧫 KinExA📡 SPR🌊 FIDA🌡️ MST
FormatIn-solution + bead columnSurface-based (chip)In-solution (capillary)In-solution (capillary)
ModificationEquilibrium pair unmodified*One partner immobilizedOne partner labeledOne partner labeled
KD floorfM, well-optimisedpM, MW-dependent~10–100 pMpM–nM, MW/dye-dependent
OutputKD, active conc, kon (slow)kon, koff, KDRh + KDKD
ThroughputLowHighModerateHigh
Best forTight KD, unmodified pairsKineticsKD in crude matricesScreening KD

*KinExA: the equilibrium pair stays unmodified, but the assay still requires an antigen-coated bead column and a labeled detection reagent — both contacted only after equilibrium is reached.

Publication Checklist

🔬 Experimental

  • ☐ Instrument and software version
  • ☐ Bead chemistry and antigen coating density
  • ☐ Antibody and antigen concentrations (each curve)
  • ☐ Equilibration time and temperature
  • ☐ Buffer / matrix composition
  • ☐ Detection antibody and label
  • ☐ Sample volume per measurement
  • ☐ Number of replicates and curve types (n / k)

📊 Analysis

  • ☐ Binding model (1:1) and fitting software
  • ☐ KD with 95% CI (not just point estimate)
  • ☐ Active concentrations from k-curve
  • ☐ Combined n + k fit residuals
  • ☐ Equilibration verified (time-course at lowest [Ag])
  • ☐ Negative / non-binding controls
  • ☐ kon (if reported) with method and time points

🔧 Instruments & Software

Instruments

  • KinExA 4000 (Sapidyne Instruments) — current flagship. Auto-sampler, multi-position bead pack, fluorescence detection
  • KinExA 3200 (Sapidyne Instruments) — earlier-generation instrument, still in widespread use

Software

  • KinExA Pro (Sapidyne) — equilibrium & kinetics fitting, n/k-curve combination, confidence intervals
  • Custom scripts — Python / R for non-1:1 models, global fits across constructs

Have SPR or BLI data?

Upload your raw files and get an automated kinetic analysis in minutes. We support Biacore, Octet, and other major formats.

Upload & Analyze